April 26, 2016
SILVER SPRING, Md. — The Food and Drug Administration has approved Exelixis’ Cabometyx (cabozantinib) tablets, the company announced this week. Cabometyx is indicated to treat patients with advanced renal cell carcinoma who have previously received anti-angiogenic treatment.   
April 26, 2016

The Innovation symposium on pharmacy automation solutions earlier this month included a tour of Binghamton University's Thomas J. Watson School of Engineering and Applied Science’s new building.

April 26, 2016

See photos from the welcome reception for Innovation and Binghamton University’s Watson Institute for Systems Excellence's pharmacy automation symposium. 

April 26, 2016
PrescribeWellness has added five new members to its Pharmacy Advisory Board, the company announced Tuesday. 
April 26, 2016

The researchers are currently conducting a National Health and Medical Research Council study using a combination of these nutraceuticals for depression.

April 26, 2016

The needs of pharmacies looking to incorporate high-volume automation into their central fill or mail-order prescription fulfillment process vary from operation to operation, Innovation executives and Binghamton University faculty members said at a symposium held earlier this month at the university's Watson Institute for Systems Excellence.

April 26, 2016

A new partnership between the two companies will see development and commercialization of generics with a high technological barrier. 

April 25, 2016

The drug had an estimated market size of about $4.2 billion for the 12 months ending February 2016, according to IMS Health. 

April 25, 2016
The new indication for Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets) will allow it to be used for patients with genotype 1b chronic hepatitis C and compensated cirrhosis. 
April 25, 2016
Miller was most recently an attorney with the DEA’s diversion control area, where she advised the agency on controlled substance listed chemical regulation. 
 
April 25, 2016

Perrigo's new CEO led the company's U.S. Consumer Healthcare business from 2003 to 2006

April 25, 2016

Recently resigned Perrigo chairman and CEO Joseph Papa has joined Valeant Pharmaceuticals as its CEO.

April 25, 2016

The drug is a synthetic androgen available in 100-count bottles of 10-mg tablets. 

April 22, 2016
Allergan on Thursday announced that it had acquired topical dermatology company Topokine Therapeutics, which develops medicine for fat reduction.
April 22, 2016

The clinic initiative follows a successful pilot in 2015, which featured what the chain said was the first oral cancer screening in a pharmacy. 

April 22, 2016
The drug had U.S. sales of about $39 million for the 12 months ended December 2015, according to IMS Health. 
 
April 21, 2016

AbbVie and the University of Chicago announced this week a new five-year collaboration to advance oncology medical research and improve the pace of discovery for both organizations.

April 21, 2016

A new partnership between savings program company Medical Security Card (MSC)’s ScriptSave WellRx and medication management company SinfoníaRx will bring on-demand pharmacist access to users of the savings program’s app.

April 20, 2016

Dr. Reddy’s Laboratories subsidiary Promius Pharma announced Tuesday that its Zembrace SymTouch (sumatriptan injection) is now commercially available in the United Stated. 

April 20, 2016
The once-daily oral therapy had previously been approved as a first-line treatment for specific types of non-small cell lung cancer. 
April 20, 2016

The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 seeks to increase collaboration between health and enforcement bodies on drug abuse solutions.

April 20, 2016

Six months after being prescribed a specific treatment, 50% of Canadian patients do not adhere to it and this statistic has remained unchanged for the last 30 years.

April 20, 2016

The new version of the facility-to-pharmacy communications tool has features that can help long-term care (LTC) facilities access patient information and quickly order prescription refills. 

April 20, 2016

The drug is indicated to treat attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and older.